Amgen Complaint Against Roche Accepted By ITC
The U.S. International Trade Commission has agreed to review Amgen's complaint against Roche regarding Roche's importation of pegylated recombinant human erythropoietin, Amgen announced May 9
The U.S. International Trade Commission has agreed to review Amgen's complaint against Roche regarding Roche's importation of pegylated recombinant human erythropoietin, Amgen announced May 9